Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Carbonic Anhydrase IX as a Marker of Disease Severity in Obstructive Sleep Apnea. | Medicina (Kaunas) | 2022 | 36422182 | PubTator, text mining | PubMed |
| Carbonic Anhydrase Inhibitors from Marine Natural Products. | Mar Drugs | 2022 | 36422000 | PubTator, text mining | PubMed |
| Aza-BODIPY based carbonic anhydrase IX: Strategy to overcome hypoxia limitation in photodynamic therapy. | Front Chem | 2022 | 36405312 | PubTator, text mining | PubMed |
| Plasma proteomic characterization of the development of acute kidney injury in early sepsis patients. | Sci Rep | 2022 | 36385130 | PubTator, text mining | PubMed |
| CAXII Is a Surrogate Marker for Luminal Breast Tumors Regulated by ER and GATA3. | Cancers (Basel) | 2022 | 36358871 | PubTator, text mining | PubMed |
Quantification of promoting efficiency and reducing toxicity of Traditional Chinese Medicine: A case study of the combination of Tripterygium wilfordii hook. f. and Lysimachia christinae hance in the treatment of lung cancer. | Front Pharmacol | 2022 | 36339610 | PubTator, text mining | PubMed |
| Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. | J Hematol Oncol | 2022 | 36319992 | PubTator, text mining | PubMed |
| Protein-Labeling Fluorescent Probe Reveals Ectodomain Shedding of Transmembrane Carbonic Anhydrases. | ACS Chem Biol | 2022 | 36318872 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of the Anticancer Effects of Annatto Tocotrienol, Delta-Tocotrienol and Gamma-Tocotrienol on Chondrosarcoma Cells. | Nutrients | 2022 | 36296960 | PubTator, text mining | PubMed |
| Efficient Synthesis with Green Chemistry Approach of Novel Pharmacophores of Imidazole-Based Hybrids for Tumor Treatment: Mechanistic Insights from In Situ to In Silico. | Cancers (Basel) | 2022 | 36291864 | PubTator, text mining | PubMed |
| Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment. | Nat Commun | 2022 | 36271074 | PubTator, text mining | PubMed |
| Picomolar fluorescent probes for compound affinity determination to carbonic anhydrase IX expressed in live cancer cells. | Sci Rep | 2022 | 36271018 | PubTator, text mining | PubMed |
| New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells. | J Med Chem | 2022 | 36269278 | PubTator, text mining | PubMed |
| Probing predilection to Crohn's disease and Crohn's disease flares: A crowd-sourced bioinformatics approach. | J Pathol Inform | 2022 | 36268056 | PubTator, text mining | PubMed |
| Identification of miRNA-mRNA-TFs regulatory network and crucial pathways involved in asthma through advanced systems biology approaches. | PLoS One | 2022 | 36264868 | PubTator, text mining | PubMed |
| Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF-7/SC Breast Cancer Cells. | Int J Mol Sci | 2022 | 36232636 | PubTator, text mining | PubMed |
| Role of the Hedgehog Pathway and CAXII in Controlling Melanoma Cell Migration and Invasion in Hypoxia. | Cancers (Basel) | 2022 | 36230699 | PubTator, text mining | PubMed |
| The construction of a hypoxia-based signature identified CA12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression. | Front Oncol | 2022 | 36226072 | PubTator, text mining | PubMed |
| Molecular characteristics of a coxsackievirus A12 strain in Zhejiang of China, 2019. | Virol J | 2022 | 36224635 | PubTator, text mining | PubMed |
| Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation. | Cell Rep Med | 2022 | 36223777 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=16